Lumexa Imaging Financial Statements
NASDAQ: LMRIHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Lumexa Imaging has no annual income statement on file yet, so quarterly figures are shown instead.
Lumexa Imaging revenue and earnings
In the quarter ended Jun 30, 2026, Lumexa Imaging generated $264.2 million in revenue. Net income was $2.7 million, for a net margin of 1.0% versus a median of -2.9% in the prior 3 quarters. Operating margin was 8.7%.
Diluted earnings per share came in at $0.03.
Summary generated from market data by MetaCap's automated system. Methodology
Lumexa Imaging income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Revenue | 264.16M | 252.54M | 251.40M | 245.00M |
| Revenue growth (YoY) | — | — | — | — |
| Operating Expenses | 259.74M | 248.15M | 240.25M | 234.78M |
| Operating Income | 23.04M | 19.41M | 27.68M | 25.54M |
| Interest Expense | 16.22M | 16.33M | 30.10M | 29.85M |
| Other Income (Expense) | -17.27M | — | -30.10M | — |
| Pretax Income | 5.76M | 3.08M | -2.42M | -4.31M |
| Income Tax | 3.02M | 1.36M | 4.81M | 3.38M |
| Net Income | 2.75M | 1.72M | -7.23M | -7.69M |
| Net Income growth (YoY) | — | — | — | — |
| EPS (Basic) | 0.03 | 0.02 | -0.10 | -0.11 |
| EPS (Diluted) | 0.03 | 0.02 | -0.10 | -0.11 |
| Shares Outstanding (Basic) | 95.98M | 95.98M | 69.53M | 69.52M |
| Shares Outstanding (Diluted) | 96.04M | 95.98M | 69.53M | 69.52M |
| EBITDA | 33.12M | 29.33M | 36.96M | 34.59M |
| Operating Margin | 8.72% | 7.69% | 11.01% | 10.42% |
| Net Margin | 104.00% | 68.00% | -2.87% | -3.14% |
This table shows 4 quarterly periods of Lumexa Imaging's income statement, from Q2 2026 back to Q? 2025, across 15 line items including revenue, operating expenses, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow LMRI's reporting calendar. What is a income statement?